Metohexal

Metoprolol Tartrate, the active ingredient in Metohexal, is a beta‑blocker presented as an oral tablet for oral use. It treats hypertension, angina pectoris, post‑myocardial infarction, chronic heart failure and certain cardiac arrhythmias in adult patients.

GNH USA supplies Metohexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metohexal is a beta‑blocker that acts on the cardiovascular system to control blood pressure and reduce cardiac workload.

Hypertension: lowers systemic blood pressure by decreasing heart rate and cardiac output. Angina pectoris: reduces myocardial oxygen demand, relieving chest pain. Post‑myocardial infarction: helps prevent recurrent cardiac events by stabilising heart rhythm. Chronic heart failure: improves survival by decreasing ventricular workload. Certain cardiac arrhythmias: controls heart rate and rhythm in selected arrhythmic conditions.

Metohexal may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities or peripheral vasoconstriction - Gastrointestinal upset (nausea, abdominal discomfort) - Sleep disturbances or vivid dreams

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma - Acute decompensated heart failure - Allergic reactions such as rash or angioedema - Cardiogenic shock in rare cases

Before initiating Metohexal, clinicians should evaluate patient-specific risk factors and monitor therapy closely.

Cardiovascular assessment: check baseline heart rate and blood pressure. Respiratory status: avoid in uncontrolled asthma or severe chronic obstructive pulmonary disease. Diabetes monitoring: be aware of masked hypoglycaemia symptoms. Pregnancy counseling: discuss potential risks, as the drug is category C. Drug discontinuation: taper gradually to prevent rebound hypertension. Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Metohexal can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective beta‑blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): increased risk of AV block. - Abrupt clonidine withdrawal: may precipitate severe rebound hypertension.

Moderate Interactions (Monitor Closely): - Diuretics: enhanced hypotensive effect, monitor electrolytes. - ACE inhibitors or ARBs: watch renal function and potassium levels. - Antidiabetic agents: possible masking of hypoglycaemia signs, adjust monitoring.